Estrogenic regulation of cocaine sensitization

可卡因致敏的雌激素调节

基本信息

项目摘要

Clinical and preclinical studies indicate gender differences in the prevalence of cocaine dependence, response to treatment and in relapse that are unrelated to differences in the pharmacokinetics of the drug. Our long term goal is to understand the neurobiological mechanisms that contribute to gender differences in drug addiction. Identifying the mechanisms that mediate differences in vulnerability to drugs of abuse may lead to effective therapeutic strategies for the treatment and prevention of addiction and relapse. Animal studies show sex differences in cocaine-induced behavioral sensitization, characterized by an increase in locomotor activity upon repeated cocaine exposure. Sensitization involves long-term adaptations in neural circuitry that mirror the increase in drug craving in addicts, promoting its use to study motivational components of addictive behavior. In females, estrogen potentiates behavioral sensitization by mechanisms still unclear. Data from recent neuroimaging studies implicate frontal cortical areas in drug craving. Moreover, we have shown that opioid modulation of cocaine-induced sensitization in females is different from that observed in males and varies with estrogen plasma levels. A decrease in mu opioid receptor density in the nucleus accumbens was also observed. It is hypothesized that estrogen facilitates cocaine sensitization by: (1) amplifying mu opioid signaling in the nucleus accumbens. (2) potentiating the metabolic response of frontal cortical neurons to cocaine. Changes in neural activity in cocaine-sensitized male and female rats as well as in ovariectomized rats with and without estrogen will be ascertained in the prefrontal cortex and anterior cingulate by functional magnetic resonance imaging (fMRI). Endogenous mu ligands and receptors in the nucleus accumbens will be studied by in situ hybridization, immunohistochemistry, autoradiography and mu-ligand induced 35S yGTP binding and by pharmacological manipulations and behavioral testing. The use of behavioral, pharmacological and neurochemical data together with fMRI will provide us with an integrated approach to examine the effects of cocaine, and its correlation with gonadal hormonal status, on neural substrates of the female. The proposed research is unique since/t is the first time that conscious awake animals will be used to identify sites in the brain that respond to repeated cocaine administration.
临床和临床前研究表明,可卡因依赖流行率、对治疗的反应和复发率存在性别差异,这与药物的药代动力学差异无关。我们的长期目标是了解导致药物成瘾性别差异的神经生物学机制。查明在易受药物滥用影响方面存在差异的调节机制,可能有助于制定治疗和预防成瘾和复吸的有效治疗战略。动物研究表明,可卡因诱导的行为敏化的性别差异,其特征是在重复接触可卡因后自发活动增加。致敏涉及长期 神经回路的适应反映了成瘾者对药物渴望的增加,促进其用于研究成瘾行为的动机成分。在女性中,雌激素增强行为敏感化的机制尚不清楚。最近的神经影像学研究数据表明,额叶皮质区与药物渴求有关。此外,我们已经表明,阿片类药物调制可卡因诱导的致敏作用在女性中是不同的,从男性中观察到的,并与雌激素血浆水平。还观察到丘脑核中μ阿片受体密度降低。据推测,雌激素通过以下方式促进可卡因致敏:(1)放大丘脑核中的μ阿片样物质信号传导。(2)增强额叶皮层神经元对可卡因的代谢反应。可卡因致敏的雄性和雌性大鼠以及卵巢切除大鼠(有和无雌激素)的神经活动变化将通过功能性磁共振成像(fMRI)在前额叶皮层和前扣带回中确定。将通过原位杂交、免疫组织化学、放射自显影和mu-配体诱导的35 S yGTP结合以及药理学操作和行为测试来研究髓核中的内源性mu配体和受体。使用行为,药理学和神经化学数据与功能磁共振成像将为我们提供一个综合的方法来检查可卡因的影响,及其与性腺激素状态的相关性, 雌性的神经基质这项研究是独一无二的,因为/t是第一次 将使用清醒的动物来鉴定脑中对重复给予可卡因有反应的部位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANNABELL C SEGARRA其他文献

ANNABELL C SEGARRA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANNABELL C SEGARRA', 18)}}的其他基金

ACT 3: RESOURCE CENTER FOR CELL IMAGE ANALYSIS
第 3 步:细胞图像分析资源中心
  • 批准号:
    7336040
  • 财政年份:
    2006
  • 资助金额:
    $ 10.19万
  • 项目类别:
ACT 3: RESOURCE CENTER FOR CELL IMAGE ANALYSIS
第 3 步:细胞图像分析资源中心
  • 批准号:
    7164315
  • 财政年份:
    2005
  • 资助金额:
    $ 10.19万
  • 项目类别:
ACT 3: RESOURCE CENTER FOR CELL IMAGE ANALYSIS
第 3 步:细胞图像分析资源中心
  • 批准号:
    7011418
  • 财政年份:
    2004
  • 资助金额:
    $ 10.19万
  • 项目类别:
Estrogen and Cocaine Sensitization in the Female Rat
雌性大鼠的雌激素和可卡因致敏作用
  • 批准号:
    6766989
  • 财政年份:
    2004
  • 资助金额:
    $ 10.19万
  • 项目类别:
A8: CELL IMAGE ANALYSIS RESOURCE CENTER: IN SITU HYBRIDIZATION
A8:细胞图像分析资源中心:原位杂交
  • 批准号:
    6657692
  • 财政年份:
    2002
  • 资助金额:
    $ 10.19万
  • 项目类别:
A8: CELL IMAGE ANALYSIS RESOURCE CENTER: IN SITU HYBRIDIZATION
A8:细胞图像分析资源中心:原位杂交
  • 批准号:
    6646694
  • 财政年份:
    2002
  • 资助金额:
    $ 10.19万
  • 项目类别:
A8: CELL IMAGE ANALYSIS RESOURCE CENTER: IN SITU HYBRIDIZATION
A8:细胞图像分析资源中心:原位杂交
  • 批准号:
    6341297
  • 财政年份:
    2000
  • 资助金额:
    $ 10.19万
  • 项目类别:
A8: CELL IMAGE ANALYSIS RESOURCE CENTER: IN SITU HYBRIDIZATION
A8:细胞图像分析资源中心:原位杂交
  • 批准号:
    6216717
  • 财政年份:
    1999
  • 资助金额:
    $ 10.19万
  • 项目类别:
A8: CELL IMAGE ANALYSIS RESOURCE CENTER: IN SITU HYBRIDIZATION
A8:细胞图像分析资源中心:原位杂交
  • 批准号:
    6205959
  • 财政年份:
    1999
  • 资助金额:
    $ 10.19万
  • 项目类别:
OPIOID IN RNAS AND SEROTONERGIC RECEPTORS IN HIPPOCAMPUS OF EPILEPTIC PATIENTS
癫痫患者海马 RNAS 和血清素受体中的阿片类药物
  • 批准号:
    6206484
  • 财政年份:
    1999
  • 资助金额:
    $ 10.19万
  • 项目类别:

相似海外基金

Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics
利用 PET 研究微塑料和纳米塑料的体内命运和健康影响
  • 批准号:
    10890903
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
亚型选择性代谢型谷氨酸受体 PET 配体
  • 批准号:
    10576674
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Neural Basis of Stress-Derailed Motherhood
压力脱轨母性的神经基础
  • 批准号:
    10666891
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Altered microglia states and microglia-endothelial cell axis in relation to white matter disease progression in VCID
VCID 中小胶质细胞状态和小胶质细胞内皮细胞轴的改变与白质疾病进展相关
  • 批准号:
    10738860
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
  • 批准号:
    10663717
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
糖原合成酶激酶 3 配体发现治疗阿尔茨海默病
  • 批准号:
    10637434
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Assessing Diffusion MRI Metrics for Detecting Changes of Synaptic Density in Alzheimer's Disease
评估弥散 MRI 指标以检测阿尔茨海默病突触密度的变化
  • 批准号:
    10739911
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
支持在吸烟者 2 期临床研究中评估 mGlu2 PAM SBP-9330 的安全性/毒理学、ADME 和 CMC 活动
  • 批准号:
    10829189
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Probing D2 and 5HT-2A mechanisms in early visual processing in V1
探索 V1 早期视觉处理中的 D2 和 5HT-2A 机制
  • 批准号:
    10605769
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
Develop in vivo PET imaging probes for ROCK2 as a biomarker of early Alzheimer's disease.
开发 ROCK2 的体内 PET 成像探针作为早期阿尔茨海默病的生物标志物。
  • 批准号:
    489145
  • 财政年份:
    2023
  • 资助金额:
    $ 10.19万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了